The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1263 articles
On The View, Joy Behar opened up about her GLP-1 weight loss success, noting she was prediabetic before starting. Co-host Sunny Hostin shared gaining 40 lbs during COVID and using Mounjaro to improve her cholesterol from 200 to 140. These stories highlight Hollywood's trend toward Ozempic and similar drugs for real health gains.
Peptides are everywhere on TikTok, with gym bros claiming stacks like Ipamorelin and CJC1295 supercharge muscle growth and recovery. But do these injectable amino acid chains really deliver, or is it hype? Experts weigh in on the science, safety, and why caution is key amid a $81.5 billion industry boom.
Emerging evidence suggests GLP-1 receptor agonists (GLP-1 RAs) not only aid weight loss but also significantly quiet 'food noise'—those persistent, distressing thoughts about food. In the US-based INFORM survey, 550 individuals using GLP-1s reported a 46% reduction in constant food thoughts, alongside mental health gains. This could redefine obesity management for better holistic outcomes.
Gonadorelin 5mg research peptide is gaining traction in studies of hormonal health and reproductive medicine. This synthetic GnRH mimic helps researchers investigate gonadotropin release, hormonal imbalances, and therapies for conditions like hypogonadism. Delve into its mechanisms, efficacy metrics, and essential ethical considerations for robust clinical research.
New research reveals a stark 'Mounjaro gap' in weight-loss drug access, with middle-class women far more likely to use GLP-1 jabs like Mounjaro privately, deepening class divides. Patients like Kelly Todd face years-long NHS waits despite eligibility. Experts warn this entrenches health inequalities amid high private costs of £144-£324 monthly.
Global food giants like PepsiCo and Coca-Cola are ramping up investments in rebranded, protein-rich products as GLP-1 drugs suppress appetite and alter eating habits across 20% of U.S. households. With potential $12 billion in lost snack sales over the next decade, companies are shifting to smaller portions and nutrient-dense options. This adaptation highlights the lasting ripple effects of obesity medications on the food industry.
On The View, Joy Behar, 83, proudly shared losing 25 lbs on a GLP-1 medication, boasting 'We all did it!' alongside Whoopi Goldberg and guest Savannah Chrisley. The co-hosts opened up about their transformative weight loss experiences with drugs like Ozempic and Mounjaro. This candid discussion highlights the growing popularity of GLP-1s among celebrities.
GLP-1 medications like those approved for weight loss can transform your journey, but nutrition plays a key role in maximizing benefits. A pilot clinical trial by Atkins shows that pairing GLP-1s with higher protein and fiber helps maintain healthier body composition. These 4 tips—fiber, protein, hydration, and small meals—can help you feel energized and supported.
Indian drugmaker Dr Reddy's Laboratories is gearing up to launch a generic version of Novo Nordisk's Wegovy at prices up to 60% lower than the original. Co-chairman G V Prasad confirmed 50-60% discounts are feasible as semaglutide's patent nears expiry in March. This could reshape access to weight-loss treatments in India's competitive market.
